4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001415889-24-026465
CFO, EVP & TREASURER sold 7,426 shares at $52.05 ($386,523)
- CFO, EVP & TREASURER acquired 7,426 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PETERS WILLIAM J CFO, EVP & TREASURER | 2024-11-06 | Option exercise 10b5-1 | +7,426 | $13.03 | $96,761 | 101,529 | D |
| PETERS WILLIAM J CFO, EVP & TREASURER | 2024-11-06 | Sale 10b5-1 | −7,426 | $52.05 | $386,523 | 94,103 | D |
| Derivatives | |||||||
| PETERS WILLIAM J CFO, EVP & TREASURER | 2024-11-06 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −7,426 | 23,674 | D | ||
| Open-market sales · 7,426 sh · avg $52.05 · $386,523 | |||||||
Loading xslF345X05/form4-11082024_101140.xml…